基于生物网络探究三七治疗类风湿关节炎的作用机制  

Mechanism of Panax notoginseng in the Treatment of Rheumatoid Arthritis Based on Biological Network

作　　者：邓茜 李湘媛 彭紫凝 毛丹宁 孟凡雨 黄元波 晏蔚田 刘念 邓春玲 彭江云 王宏 DENG Qian;LI Xiangyuan;PENG Zining;MAO Danning;MENG Fanyu;HUANG Yuanbo;YAN Weitian;LIU Nian;DENG Chunlin;PENG Jiangyun;WANG Hong(The First Clinical College,Yunnan University of Chinese Medicine,Kunming 650500,China;Rheumatology Center,the First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine,Kunming 650032,China;Dept.of Nephrology and Rheumatology,Zhaotong Hospital of Traditional Chinese Medicine,Yunnan Zhaotong 657000,China)

机构地区：[1]云南中医药大学第一临床医学院,昆明650500 [2]云南中医药大学第一附属医院/云南省中医医院风湿病中心,昆明650032 [3]昭通市中医医院肾病风湿科,云南昭通657000

出　　处：《中国医院用药评价与分析》2025年第3期266-273,278,共9页Evaluation and Analysis of Drug-use in Hospitals of China

基　　金：国家自然科学基金资助项目(No.82160901);云南省教育厅科学研究基金项目(No.2023Y0463);云南省中医(风湿病)临床医学研究中心项目(No.202405AJ310004);云南省科学技术厅医疗机构科研项目(No.202403AC100019);云南省科技厅科技计划项目(No.202301AZ070001-162)。

摘　　要：目的:运用生物信息学分析类风湿关节炎的核心基因,再通过网络药理学和分子对接法探究三七抗类风湿关节炎的作用机制。方法:根据中药成分的生物利用度在中药系统药理学数据库与分析平台、中医药信息数据库以及本草组鉴数据库检索三七的活性成分,通过Swiss Target Prediction数据库预测活性成分对应的靶点。通过GEO数据库获得的类风湿关节炎的基因芯片进行分析,利用生物信息学方法获取类风湿关节炎相关的差异表达基因,并分析类风湿关节炎相关的核心基因。取三七和类风湿关节炎的共同靶点,构建药物-成分-靶点网络,对交集靶点进行富集分析。再通过分子对接验证三七的核心成分与类风湿关节炎的核心基因之间的亲和力。结果:生物信息学分析表明,类风湿关节炎的核心基因包含鸟嘌呤核苷酸交换因子1、CD8α分子(CD8A)和脾相关酪氨酸激酶(SYK)。网络药理学结果显示,三七的58种主要化学成分可作用于类风湿关节炎的53个靶点,核心靶点包括淋巴细胞特异性蛋白酪氨酸激酶、C-X-C基序趋化因子受体4、表皮生长因子受体、颗粒酶B、过氧化物酶体增殖物激活受体γ、CD8A、基质金属蛋白酶9、SYK、整合素αL、C-X-C基序趋化因子受体3和脂肪酸合酶。对53个交集靶点进行富集分析,发现三七的主要活性成分可能通过多种生物学机制参与多条信号通路发挥抗类风湿关节炎的作用。分子对接结果表明,三七的主要活性成分与类风湿关节炎的核心基因具有良好的结合能力。结论:三七可以通过多成分、多靶点、多途径发挥抗类风湿关节炎的作用。OBJECTIVE:To analyze the core genes of rheumatoid arthritis based on bioinformatics,and explore the mechanism of anti-rheumatoid arthritis effects of Panax notoginseng through network pharmacology and molecular docking.METHODS:The active components of Panax notoginseng were searched in Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform,Traditional Chinese Medicine Integrated Database,and HERB based on the bioavailability,and the corresponding targets were predicted by Swiss Target Prediction.The rheumatoid arthritis gene chips obtained from GEO database were analyzed,and the differentially expressed genes(DEGs)associated with rheumatoid arthritis were obtained by bioinformatics method,and the core genes associated with rheumatoid arthritis were analyzed.The drug-component-target network was constructed by taking the common targets of Panax notoginseng and rheumatoid arthritis,and the enrichment analysis of the intersection genes was performed.The binding affinity between the core components of Panax notoginseng and core targets of rheumatoid arthritis was verified by molecular docking.RESULTS:The bioinformatics analysis showed that the hub genes of rheumatoid arthritis included Vav Guanine Nucleotide Exchange Factor 1,CD8αMolecule(CD8A),and Spleen Tyrosine Kinase(SYK).Results of network pharmacology showed that 58 major chemical components of Panax notoginseng could act on 53 targets of rheumatoid arthritis,and the core targets included LCK,CXCR4,EGFR,GZMB,PPARG,CD8A,MMP9,SYK,ITGAL,CXCR3,and FASN.The enrichment analysis of 53 intersection genes showed that the major active components of Panax notoginseng may participate in multiple signaling pathways through various biological mechanisms to exert anti-rheumatoid arthritis effects.Molecular docking also indicated that the core active components of Panax notoginseng had good binding ability to the hub genes of rheumatoid arthritis.CONCLUSIONS:Panax notoginseng can exert anti-rheumatoid arthritis effects through multiple components,mul

关 键 词：三七 类风湿关节炎 生物信息学 

分 类 号：R932[医药卫生—生药学] R96[医药卫生—药学]